FDA Warning Letter — Prothya Biosolutions Netherlands B.V.

Case 409469 — FEI 3007166802

The FDA took a Warning Letter action against Prothya Biosolutions Netherlands B.V. on August 29, 2013 (Amsterdam, Netherlands). The action was issued by CBER and concerns biologics products. This facility has 5 or more recent FDA inspections on record.

Action Details

Facility
Prothya Biosolutions Netherlands B.V.
Date
August 29, 2013
Fiscal Year
2013
Product Type
Biologics
Center
CBER
Location
Amsterdam (Netherlands)